Effect of tobacco use on disease activity and DMT discontinuation in multiple sclerosis patients treated with dimethyl fumarate or fingolimod.
Carrie M HershHaleigh HarrisMalissa AyersDevon S ConwayPublished in: Multiple sclerosis journal - experimental, translational and clinical (2020)
Our findings suggest that tobacco is a negative risk factor for inflammatory disease activity and earlier DMF and FTY discontinuation.